19 November 2017
News and Views
Links and Services
The latest publication of the Alimentary Pharmacology & Therapeutics examines selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases.
A link between histone deacetylases (HDACs) and intestinal inflammation has been established.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors